Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.
Chen Z, Wang D, Ma M, Li C, Wan Z, Zhang L, Zhu Y, Wang M, Wang H, He S, Peng Y, Wei J, Huang B, He Y; OPTIMAL-REPERFUSION trial investigator. Chen Z, et al. Among authors: peng y. Clin Cardiol. 2021 Apr;44(4):455-462. doi: 10.1002/clc.23582. Epub 2021 Feb 25. Clin Cardiol. 2021. PMID: 33634478 Free PMC article. Clinical Trial.
The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance.
Lan J, Chen X, Chen X, Wang S, Zhang X, Wu K, He S, Peng Y, Jiang L, Li L, Wan L. Lan J, et al. Among authors: peng y. Diabetes Res Clin Pract. 2011 Oct;94(1):71-6. doi: 10.1016/j.diabres.2011.05.039. Epub 2011 Jul 13. Diabetes Res Clin Pract. 2011. PMID: 21742399 Clinical Trial.
20,281 results
You have reached the last available page of results. Please see the User Guide for more information.